Migraine (Pediatric)

    Not Recruiting
Updated on 14 August 2022
nasal spray
acute treatment
acute migraine


To evaluate the efficacy and safety of zolmitriptan nasal spray (ZNS) in the acute treatment of migraine headache in subjects ages 6 to 11 years.

Eligibility Criteria:

Each child must have a responsible trained adult with knowledge of the conduct of the study and must be available to supervise migraine treatment and study requirements. Parent or legal guardian is able to provide written informed consent and subject is able to provide written assent.

Condition Migraine, Migraine (Pediatric), Migraine (Adult), Pediatrics, Migraine (Adult), Migraine (Pediatric)
Clinical Study IdentifierTX133687
Last Modified on14 August 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note